Molecules · 2021 · 19 citations · 22 references
MedicineDermatologyPharmacologyCell SignalingImmunoregulationInflammationAnti-inflammatory PharmacologyCytokine BiologyInflammatory DermatosesInflammatory SignalingInflammatory Skin DiseasesInflammatory Skin DisordersAnti-inflammatory MechanismsAnti-inflammatory TherapeuticsInflammatory Skin ResponsesKeratinocyte ActivationPsoriasis ModelsPsoriasis TherapyPsoriatic DiseaseTopical Imiquimod
Psoriasis is a chronic inflammatory skin disease accompanied by excessive keratinocyte proliferation. Corticosteroids, vitamin D3 analogs, and calcineurin inhibitors, which are used to treat psoriasis, have diverse adverse effects, whereas natural products are popular due to their high efficiency and relatively low toxicity. The roots of the Cudrania tricuspidata (C. tricuspidata) are known to have diverse pharmacological effects, among which the anti-inflammatory effect is reported as a potential therapeutic agent in skin cells. Nevertheless, its effectiveness against skin diseases, especially psoriasis, is not fully elucidated. Here, we investigated the effect of cudraxanthone D (CD), extracted from the roots the C. tricuspidata Bureau, on psoriasis using an imiquimod (IMQ)-induced mouse model and the tumor necrosis factor (TNF)-α/interferon (IFN)-γ-activated keratinocytes. IMQ was topically applied to the back skin of C57BL/6 mice for seven consecutive days, and the mice were orally administered with CD. This resulted in reduced psoriatic characteristics, such as the skin thickness and Psoriasis Area Severity Index score, and the infiltration of neutrophils in IMQ-induced skin. CD inhibited the serum levels of TNF-α, immunoglobulin G2a, and myeloperoxidase, and the expression of Th1/Th17 cells in splenocytes. In TNF-α/IFN-γ-activated keratinocytes, CD reduced the expressions of CCL17, IL-1β, IL-6, and IL-8 by inhibiting the phosphorylation of STAT1 and the nuclear translocation of NF-kB. Taken together, these results suggest that CD could be a potential drug candidate for the treatment of psoriasis.
22
Durable and controlled depletion of neutrophils in mice
Gaël Boivin, Julien Faget, Pierre‐Benoit Ancey et al. · Nature Communications · 2020 · 297 citations · Full text
Mechanisms of Action of Topical Corticosteroids in Psoriasis
Luís Uva, Diana Miguel, Catarina Pinheiro et al. · International Journal of Endocrinology · 2012 · 233 citations · Full text